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Abstract. Leukocyte emigration possibly requires dy- 
namic regulation of integrin adhesiveness for endothe- 
lial and extracellular matrix ligands. Adhesion assays 
on purified vascular cell adhesion molecule (VCAM)-I, 
fibronectin, and fibronectin fragments revealed distinct 
kinetic patterns for the regulation of very late antigen 
(VLA)-4 (a4131) and VLA-5 (et5131) avidity by the CC 
chemokines monocyte inflammatory protein (MIP)-la, 
RANTES (regulated on activation, normal T expressed 
and secreted), or monocyte chemoattractant protein 
(MCP)-I in monocytes. CC chemokines induced early 
activation and subsequent deactivation of VLA-4, 
whereas upregulation of VLA-5 avidity occurred later 
and persisted. Controlled detachment assays in shear 
flow suggested that adhesive strength of VLA-4 for 
VCAM-1 or the 40-kD fragment of fibronectin (FN40) 
is more rapidly increased and subsequently reduced by 
MCP-1 than by MIP-la, and confirmed late and sus- 
tained activation of the adhesive strength of VLA-5 for 
the 120-kD fragment of fibronectin (FN120). Mn  2÷ or 
the stimulating 131 mAb TS2/16 strongly and stably en- 
hanced monocyte binding to VCAM-1 or fibronectin, 
and locked [31 integrins in a high avidity state, which 
was not further modulated by CC chemokines. Mn  2÷ 
and mAb TS2/16 inhibited CC chemokine-induced 
transendothelial migration, particularly chemotaxis 
across stimulated endothelium that involved VLA-4 
and VCAM-1. VLA-4 on Jurkat cells is of constitu- 
tively high avidity and interfered with migration across 
barriers expressing VCAM-1. Low but not high site 
densities of VCAM-1 or FN40 promoted, while FN120 
impaired, 131 integrin-dependent monocyte chemotaxis 
to MCP-1 across filters coated with these substrates. 
Thus, we show that CC chemokines can differentially 
and selectively regulate avidity of integrins sharing 
common 13 subunits. Transient activation and deactiva- 
tion of VLA-4 may serve to facilitate transendothelial 
diapedesis, whereas late and prolonged activation of 
VLA-5 may mediate subsequent interactions with the 
basement membrane and extracellular matrix. 
T  RANSENDOTHELIAL migration  of  leukocytes  into 
sites of inflammation is regulated by traffic signal 
molecules, displayed on activated endothelium, which 
are considered to act sequentially (7,  59).  Tethering and 
rolling of leukocytes on the vessel wall (39)  results in ex- 
posure to chemoattractants, such as chemokines presented 
in the endothelial proximity. Chemokines are divided into 
two subfamilies according to sequence homology and the 
arrangement of the first cysteines. CXC chemokines pref- 
erentially stimulate neutrophils, and CC chemokines pref- 
erentially  stimulate  monocytes, T  lymphocytes, eosino- 
phils, and basophils (2). Chemokines can be found associated 
with the endothelial surface or complexed to proteogly- 
can-containing moieties in the subendothelial extracellular 
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matrix (ECM) 1 (52).  Immobilized or soluble chemokines 
induce adhesion of leukocytes to endothelium or purified 
ligands, implicating their role in integrin activation (14, 29, 
59, 60).  Integrins bind to Ig superfamily members on en- 
dothelium. Like selectins, a4 integrins can support rolling. 
The integrins et4131 and et4137 mediate rolling on vascular 
cell adhesion molecule (VCAM)-I and mucosal addressin 
cell adhesion molecule (MAdCAM)-I, respectively (1, 5). 
After activation, 132 integrins and or4 integrins on leuko- 
cytes support firm adhesion (1, 39).  Chemokine gradients 
can promote diapedesis of leukocytes (29), stimulating di- 
1. Abbreviations used in this paper: BCECF/AM, 2',7'-bis-2-carboxyethyl- 
5-(6)-carboxyfluorescein-acetoxymethylester; ECM, extracellular matrix; 
HSA, human serum albumin; HUVEC, human umbilical vein endothelial 
cell; ICAM, intercellular adhesion molecule; IL, interleukin; MCP, mono- 
cyte  chemoattractant  protein;  MIP,  monocyte  inflammatory  protein; 
RANTES,  regulated  on  activation,  normal  T  expressed  and  secreted; 
TNF-c~, tumor necrosis factor a; VCAM, vascular cellular adhesion mole- 
cule; VLA, very late antigen. 
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grin-ligand interactions. Diapedesis in vivo requires sig- 
naling via G protein-coupled receptors (3, 22, 48, 58). The 
multistep paradigm provides the combinatorial diversity 
to explain the selective localization of leukocyte classes 
and subsets in various inflammatory states (7, 59).  How- 
ever, the mechanisms by which integrins mediate or facili- 
tate  leukocyte diapedesis  and  chemotaxis remain  to  be 
elucidated. 
Monocytes, eosinophils and lymphocytes but not neu- 
trophils express the 131 integrin very late antigen (VLA)-4 
(a4131, CD49d/CD29) (26), which binds to domains 1 and 
4 of VCAM-1, an Ig superfamily member induced by cy- 
tokines on endothelium (18, 50, 61, 62). VLA-4 also binds 
to an alternatively spliced domain of fibronectin, which is 
distinct from the domain containing the sequence RGD to 
which the integrin VLA-5 (~x5131) binds (30, 63).  In vitro 
studies suggest that transendothelial migration of mono- 
cytes, T lymphocytes, and eosinophils is mainly mediated 
by interaction of 132 integrins with intercellular adhesion 
molecule (ICAM)-I (17, 45, 49, 53). However, interactions 
of VLA-4 and VCAM-1 contribute to migration of resting 
T  lymphocytes, monocytes, and eosinophils across cyto- 
kine-stimulated endothelium, independently of 132  inte- 
grins (11,  17, 45, 49).  This is also consistent with in vivo 
studies showing a  role of VLA-4 in migration of mono- 
cytes  and  lymphocytes into  inflammatory sites  or  cyto- 
kine-induced lesions, after upregulation of endothelial ad- 
hesion molecules (31, 32, 66). 
Adhesion to ECM glycoproteins such as fibronectin, via 
VLA-4 and VLA-5, has been implicated in leukocyte mi- 
gration into inflammatory sites (20).  While activating 131 
mAb and T  cell receptor cross-linking stimulate 131 inte- 
grin-mediated adhesion to fibronectin by increasing affin- 
ity, phorbol esters affect postreceptor occupancy events, 
such as cytoskeletal reorganization and spreading (19, 56). 
Chemokines have also been shown to modulate 131 inte- 
grin-dependent binding of lymphocytes to secreted ECM 
(9, 23). 
In contrast with the a5 cytoplasmic domain, the cyto- 
plasmic domain of et4 has recently been described to ex- 
hibit distinct properties  essential for extravasation, sup- 
porting cell  migration over  adhesion  strengthening and 
spreading (37). Binding of VLA-4 to VCAM-1 on the en- 
dothelial surface and binding of VLA-4 and VLA-5 to fi- 
bronectin in the basement membrane would be expected 
to  function  in  distinct  steps  of  monocyte  diapedesis. 
Hence, we speculated that these integrins may differ in the 
kinetics of activation by chemokines. Here, we show that 
CC chemokines differentially and selectively regulate ad- 
hesiveness of VLA-4 and VLA-5 in monocytes. Transient 
activation and deactivation of VLA-4 precedes  late and 
persistent activation of VLA-5. This sequential modula- 
tion may be crucial in facilitating transendothelial chemo- 
taxis. 
Materials and Methods 
Reagents and mAbs 
The human recombinant chemokines and cytokines macrophage inflam- 
matory protein (MIP)-let, RANTES (regulated on activation, normal T 
expressed and secreted), monocyte chemoattractant protein (MCP)-I, in- 
terleukin (IL)-8 and tumor necrosis factor c~ (TNF-cQ were from Genzyme 
Corp. (Cambridge, MA). Accudenz was from Accurate Chemical and Sci- 
entific Corp. (Westbury, NY), and T,7'-bis-2-carboxyethyl-5-(6)-carboxy- 
fluorescein-acetoxymethylester  (BCECF/AM)  was  from  Molecular 
Probes Inc. (Eugene, OR). Other reagents were from Sigma Chemical Co. 
(St. Louis, MO). The routine IgG myeloma X63, TS1/18 (CD18) (54), and 
R6.5  (ICAM-1) (57) were purified with protein A. 4B4 (CD29, ascites) 
(47) was a generous gift from Dr. C. Morimoto (Dana-Farber Cancer In- 
stitute, Boston, MA). Purified HAE-2a (VCAM-1) (62) was a  generous 
gift from Dr. T. Tedder (Duke University, Durham, NC). Purified TS2/16 
(131 activating) (27) and A5-PUJ1 (CD49e, ascites) were kind gifts from 
Dr. M.E. Hemler (Dana-Farber Cancer Institute, Boston, MA). Purified 
Dreg 56 (L-selectin) was a  kind gift from Dr. T. Kishimoto (Boehringer 
Ingelheim Pharmaceuticals Inc., Ridgefield, CT). Purified HP2/1 (CD49d) 
(55) was from Amac, Inc. (Westbrook, ME); My4 (CD14) (25) was from 
Coulter Corp. (Hialeah, FL); and CD32 mAb was from PharMingen (San 
Diego, CA). 
Blood Cell Isolation 
Blood was collected from healthy donors and citrate-anticoagulated. Leu- 
kocyte-rich plasma was prepared by 0.6% dextran T500 sedimentation of 
erythrocytes for 45 min at room temperature. Monocytes were separated 
from lymphocytes by Accudenz 1.068  hyperosmotic gradient centrifuga- 
tion of leukocyte-rich plasma (6, 45). Platelets were removed from mono- 
cytes by four washes at 300 g for 7 min. This protocol yielded a population 
of 80-85%  monocytes as analyzed by CD14 staining and light scatter. 
Monocytes were not activated by this isolation procedure, since expres- 
sion of L-selectin, which is rapidly shed during monocyte activation, was 
identical to that on the monocyte fraction in minimally processed whole 
blood  (data  not shown), and L-selectin-mediated functions under flow 
were fully maintained (Alon, R., and T.A. Springer, unpublished data). 
Cell Culture 
Lymphoblastoid Jurkat T  cells transfected with the IL-8 receptor 2 (IL- 
8R2)  (41)  were  maintained in  RPMI  1640 medium supplemented with 
10% FCS, 50 IJ.g/ml gentamicin, and the selection antibiotic G418 (800 I~g/ 
ml; GIBCO BRL, Gaithersburg, MD). Viability was >95%, as assessed by 
trypan blue exclusion. 
Cell Adhesion Assay 
Cell attachment in stasis to VCAM-1, fibronectin, and BSA, all adsorbed 
at 2.5  I~g/ml, or a 40-kD fragment of fibronectin (FN40), a  120-kD frag- 
ment of fibronectin (FN120), and BSA, all adsorbed at 10 I~g/ml, was per- 
formed as described (44). Soluble recombinant VCAM-1 was a kind gift of 
Dr. R. Lobb (51).  Briefly, proteins were coated onto 96-well microtiter 
plates (Linbro®/Titertek  ®,  ICN  Biomedicals, Inc.,  Aurora,  OH).  Plates 
were blocked by addition of 1% human serum albumin (HSA) treated for 
2 h at 56°C.  Cells were labeled with the fluorescent dye BCECF/AM (1 
i.tg/ml),  incubated at the same time with 5%  human serum or CD32 (10 
Irg/ml) for 30 min to block Fc receptors, washed, and resuspended in assay 
medium. Blocking of Fc receptors improved the inhibition of binding to 
VCAM-1 by anti-VCAM-1 mAb, by preventing binding of monocytes to 
mAbs via Fc receptors (data not shown). Some cells were preincubated 
with blocking mAbs to VLA-4ct (HP2/1, 10 ixg/ml), VLA-5c~ (A5-PUJ1, 1: 
100 ascites), or isotype control (X63, 20 ixg/ml)  on ice for 20 min, or cy- 
tochalasin B (10 p~g/ml) for 30 rain, and washed. Some wells were preincu- 
bated with blocking mAb to VCAM-I (HAE-2a,  10 ~g/ml) and washed. 
Labeled cells (5 ×  104 in 50 ~1) were added to each well of a ligand-coated 
microtiter plate with or without chemokines, PMA (100 nM), Mn  2÷, or 
TS2/16 and allowed to settle for 10 min on ice. In some experiments, Mn  2÷ 
or TS2/16 were added 30 min after stimulation with MIP-lct. Plates were 
rapidly warmed to 37°C and incubated for indicated periods at 37°C. Fluo- 
rescence of input cells was quantified using a fluorescence concentration 
analyzer  (FCA;  Iddex,  Westbrook,  ME).  Nonadherent  cells  were  re- 
moved by a standardized washing procedure (four cycles, washing volume 
200 ~1, volume remaining after aspiration 50 p.l, with a pressure of 17,000 
Pa for Jurkat cells and 21,000 Pa for monocytes) in an automated plate 
washer (Microplate Autowasher EL-404; Bio-Tek Instruments, Inc., Wi- 
nooski. VT) using HHMC  (HBSS,  10  mM Hepes,  1 mM Mg  :+,  1 mM 
Ca  2÷, pH 7.4). The washing program minimized background binding, as 
assessed with BSA-coated control wells. Fluorescence of adherent cells 
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ing, which was typically  <5% of total, specific  binding was calculated as 
percentage of input. Data were statistically  analyzed using a paired two- 
tailed  t test with Bonferroni corrections, where indicated. 
Controlled Detachment Assay 
sVCAM-1 was adsorbed at 5 or 10 ~g/ml, and FN40 or FN120 at 30 ~g/ml 
on  plastic  dishes, and  nonspecific binding was blocked  with  2%  heat- 
treated HSA. The plastic dish was assembled as the lower wall in a parallel 
wall flow chamber and mounted on the stage of an inverted phase-con- 
trast microscope as described  (1).  Monocytes were washed  and  resus- 
pended at 5 ×  105/ml in HHMC medium supplemented with 0.2%  HSA, 
prestimulated with chemokines, PMA  (100  nM), TS2/16  (10  p~g/ml), or 
Mn  2+ (1 mM) at 37°C for the indicated  periods, and perfused through the 
chamber at flow rates to obtain defined wall shear stresses. Some cell ali- 
quots were preincubated with VLA-4 mAb (HP2/1,  10  p~g/ml), VLA-5 
mAb (A5-PUJ1, 1:100 ascites),  or isotype control mAb (X63,  10 ixg/ml). 
Experiments were quantitated as described (37). Detachment assays were 
performed on cells that were allowed to attach in stasis, at low (0.5 dyn/ 
cm  ~) or higher shear (1 dyn/cm2). For detachment, the shear flow was in- 
creased in increments every 10 s, and the number of cells per field remain- 
ing bound at the end of each 10-s interval was counted to determine the 
shear resistance of adherent cells. Data were expressed as percentage of 
cells remaining attached.  Data were statistically  analyzed using a paired 
two-tailed t test with Bonferroni corrections, where indicated. 
Flow Cytometry 
Monocytes were stimulated with or without chemokines at 37°C for 15 
rain in HHMC with 1% HSA, washed and reacted for 30 min with mAb 
on ice, washed, stained with a 1:20 dilution of goat anti-mouse [gG FITC 
(Zymed Labs, Inc., San Francisco, CA), and subjected  to scatter-gated 
flow cytometry in a FACScan  ® (Becton Dickinson & Co., Mountain View, 
CA). Staining of human umbilical  vein endothelial cells  (HUVEC) with 
mAb was as described (64). Resting HUVEC expressed ICAM-1 but not 
VCAM-1. Treatment of HUVEC with TNF-et  for 24 h upregulated sur- 
face expression of ICAM-1 and induced surface expression of VCAM-1 
(data not shown). Concentrations of mAb used for blocking experiments 
were found to be saturating both with monocytes and HUVEC (data not 
shown). 
Transendothelial and Transwell-Filter 
Chemotaxis Assay 
Isolation and culture of HUVEC was performed as described  (24,  34). 
HUVEC were grown on collagen-coated 6.5-mm-diam Transwell culture 
inserts (8-~m pore size; Costar Corp., Cambridge, MA) and treated with 
or without TNF-ct at 100 U/ml for 24 h. Transendothelial chemotaxis as- 
says were as reported (g, 53). Transwell-filters (5-p.m pore size) were also 
left uncoated or were coated with VCAM-1 at 2.5 or 10 p.g/ml, FN40 and 
FN120 at 10 or 30 Ixg/ml for 2 h at 37°C, and washed severalfold with assay 
medium.  Monocytes were incubated  with  5%  human serum or  CD32 
mAb (10 ~g/ml) for 30 min to block Fc receptors and to prevent binding 
of monocytes via Fc receptors to mAbs added in inhibition experiments. 
Jurkat cells were labeled with BCECF/AM at 1 p.g/ml for 30 rain at 37°C. 
Cells  were washed and resuspended at 5 ×  106 cells per ml in assay me- 
dium (1:1 RPMI 1640/medium  199, 0.5%  HSA). Chemokines (diluted in 
assay medium) were added to 24-well tissue-culture plates in a final  vol- 
ume of 600 p.l. Transwells were inserted into wells, and cells were added to 
the top chamber in a final volume of 100 ~LI. Monocytes were used unla- 
beled and allowed to transmigrate for 1 h. Chemotaxis of Jurkat cells was 
for 3 h at 37°C before Transwells were removed. Transmigrated and input 
mouocytes were detached with 5 mM EDTA and counted with a FACS- 
can  ® using forward and side scatter gates for monocytes. Jurkat cells were 
counted in four I0 ×  10 grids (0.1 mm per grid) per well bottom by fluo- 
rescence  microscopy. Using this method  to  quantify transmigration of 
BCECF-labeled monocytes yielded  essentially identical  results to FACS- 
can  ® analysis (data  not shown). In each experiment, the ability  of HU- 
VEC to prevent upward diffusion of low molecular weight FITC-dextran 
was assessed. For mAb inhibition studies, cells  were preincubated with 
mAb to [32 (TS1/18,  20  p~g/ml), VLA-4 (HP2/1, 10 Ixg/ml). VLA-5 (A5- 
PUJ1,  1:100 ascites),  !31  (4B4,  1:100 ascites), or isotype control (X63,  20 
p,g/ml), or endothelial monolayers in Transwells were preincubated with 
mAbs to ICAM-1 (R6.5, 20 p.g/ml), VCAM-1 (HAE-2a, 10 ~g/ml), or iso- 
type control (X63, 20 ~g/ml) for 20 min on ice. Data were statistically  ana- 
lyzed  using a paired two-tailed t test with Bonferroni corrections, where 
indicated. 
Results 
Effect of CC Chemokines on Adhesion of Monocytes 
to VCAM-1 
To  assess  the  regulation  of  131  integrin  avidity  by  CC 
chemokines, we studied adhesion of isolated human blood 
monocytes to purified  ligands.  MIP-lot or  RANTES  in- 
creased  specific  monocyte  binding  to  VCAM-1  up  to 
threefold at 12 or 15 min (Fig. 1, A and B). Binding was in- 
hibited by mAbs to VLA-4 and VCAM-1 (Fig. 1 B). This 
indicates  that  binding  was  mediated  by  interaction  of 
VLA-4  with  VCAM-1  and  that  chemokines  increase 
VLA-4 avidity. MIP-lot was most active at 10 ng/ml, and 
RANTES was most active at 100  ng/ml (Fig.  1 C).  Cells 
were incubated on the adhesive substrate in the continued 
presence or absence of chemokines for varying times (Fig. 
1  A).  While  binding  of unstimulated  cells  to  VCAM-1 
slightly  increased  at  30--60  rain,  binding  to  VCAM-1  of 
monocytes stimulated by MIP-la or RANTES markedly 
declined at 30 rain and remained lower than binding of un- 
stimulated cells up to 60 rain (Fig.  1 A). This contrasted 
with prolonged activation of VLA-4-mediated monocyte 
binding to VCAM-1 by PMA (Fig. 1 E) and reflected de- 
activation of VLA-4 and cell detachment, since binding to 
VCAM-1  was  inhibited  >90%  by a  VLA-4 mAb  at  all 
time points  (data  not  shown).  The  dose-responses  were 
similar  for  activation  and  deactivation  of  binding  to 
VCAM-1 (Fig. 1, C and D). After stimulation with MCP-1, 
VLA-4--dependent binding of monocytes to VCAM-1 was 
already reduced  at  15  min, further decreased  at 30 rain, 
and remained at 50% of resting binding up to 60 rain (Fig. 
1,  A  and  B).  The  optimal  inhibitory  concentration  for 
MCP-1  was  1 ng/ml,  as higher  and lower concentrations 
were less active (Fig. 1, C and D; data not shown). 
Mn  2+  or the activating 131  mAb TS2/16, which lock 131 
integrins  in  a  high  avidity state  (15,  44),  induced  an in- 
crease  in monocyte adhesion  to VCAM-1  that was dose 
dependent, mediated by VLA-4, and prolonged (data not 
shown).  Adding  Mn  2+  or  TS2/16  after  stimulation  with 
MIP-la for 30 rain rescued binding, indicating that VCAM-1 
was  still  functional  when  adhesion  was  reduced  by 
chemokines (Fig. 1 E). Mixing MIP-la with Mn  2+ or TS2/ 
16 showed that prolonged stimulation by the latter agents 
was dominant  and prevented the deactivation of VLA-4 
seen with chemokines at 30 rain (Fig. 1 F). 
Effect of CC Chemokines on Adhesion of Monocytes to 
Fibronectin and Fibronectin Fragments 
The kinetics of stimulation by chemokines of binding to fi- 
bronectin  and fibronectin fragments was similarly exam- 
ined. MIP-lc~ or RANTES but not MCP-1 induced a tran- 
sient increase in adhesion of monocytes to fibronectin by 
up to 50%  at 15 min, but it did not alter adhesion at 30 
min, whereas binding was reduced by MCP-1  at 15 or 30 
min  (Fig.  2  A).  At 45  or 60  min  and  up  to  90  rain,  all 
chemokines increased binding to fibronectin by up to 50% 
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Figure 1.  Transient  effects of CC chemokines on  adhesion  of 
monocytes to VCAM-1. (A and B) Kinetics (A) and inhibition by 
mAb (B) of monocyte binding to VCAM-1. (C and D) Chemo- 
kine dose-response for monocyte binding to VCAM-1 at 15 min 
(C) and 45 rain (D). (E) Kinetics of monocyte binding to VCAM-1 
in response to PMA and effect of Mn 2+ and activating [31 mAb 
TS2/16 after stimulation with MIP-la. (F) Effect of Mn  ~+ and ac- 
tivating [31  mAb TS2/16  on regulation of monocyte binding to 
VCAM-I by MIP-hx. Monocytes were subjected to adhesion as- 
says on VCAM-1 (adsorbed at 2.5 l~g/ml) in the presence of assay 
medium  (control), MIP-Ic~  (10  ng/ml),  RANTES  (100  ng/ml), 
MCP-1  (1  ng/ml).  100 nM PMA (A, B, E, and F), or indicated 
concentrations of chemokines (C and D) at 37°C for indicated 
periods (A, E, and F), 15 min (B and C), or 45 min (D). Mn  > 
(1 mM) or 131 mAb TS2/16 (10 txg/ml) were added after 30 min of 
stimulation with M1P-la (E) or mixed with  MIP-la (F).  Some 
ceils were pretreated with isotype control mAb (X63, 10 Ixg/ml) 
or VLA-4 mAb (HP2/1,  10 Ixg/ml), and some wells with VCAM-1 
mAb (HAE-2a, 10 ~g/ml) (B). Data are mean -+ SD of three in- 
dependent experiments performed in duplicate. 
(Fig. 2 A; data not shown). Inhibition with mAbs to VLA-4 
or VLA-5  revealed  that  binding  of unstimulated  mono- 
cytes was mainly mediated by VLA-5 with a <20% contri- 
bution  by VLA-4 (Fig. 2 B; compare Fig. 2  C  with 2 A). 
Marked  inhibition  was  also  achieved  by  RGD  peptide 
(data  not  shown).  After  blocking of VLA-5, binding  of 
monocytes  to  fibronectin  was  transiently  increased  by 
MIP-lc~  or  RANTES  (P  <0.01  vs  control),  but  not  by 
MCP-1  at  15  min,  and  subsequently  decreased  with  all 
chemokines (P <0.05 vs control at 45 min), remaining be- 
low binding of control cells up to 60 min (Fig. 2 B). After 
blocking of VLA-4, binding to fibronectin was unaffected 
up to 30 min but enhanced with all chemokines at 45 to 60 
min (Fig. 2 C). Thus, transient increases in adhesion to fi- 
bronectin  were  VLA-4  dependent,  while  late  increase~ 
were mediated  by activation of VLA-5. The activation of 
VLA-5 contrasted with concomitant deactivation of VLA-4 
The dose-responses for CC chemokines were identical t0r 
the  regulation  of 131  integrin  avidity  to  fibronectin  and 
VCAM-1  (data  not  shown).  PMA,  Mn >-.  or TS2/16  in- 
duced a dose-dependent increase in binding to fibronectin 
that  was  largely  VLA-5  dependent  and  was  prolonged 
(Fig. 2 D; data not shown), Mixing MIP-la with Mn 2+ o~ 
TS2/16 showed that the immediate and irreversible stimu- 
lation by the latter agents was dominant over that induced 
by CC chemokines (Fig. 2 D). 
Consistently, the CC chemokines MIP-1~ and RANTES 
transiently increased monocyte adhesion to a 40-kD frag- 
ment  of fibronectin  (FN40)  containing  the  CS-1  binding 
site for VLA-4 up to fourfold (Fig. 2 E; P  <0.01 and P  < 
0.05  vs control  lor  MIP-1a  and  RANTES,  respectively). 
All  chemokines  examined  reduced  adhesion  to FN40  al 
later time points ( Fig. 2 E; P  <  0.05 vs control at 60 min). 
By  contrast,  under  identical  conditions,  a  late  and  sus- 
tained increase in adhesion was induced to a 120-kD flag- 
ment of fibronectin (FN120) containing the RGD site for 
binding of VLA-5 (Fig. 2 F). Binding of unstimulated and 
stimulated  monocytes to FN40 and  FN120 was inhibited 
by VLA-4 and VLA-5 mAb, respectively (data not shown). 
The surface  expression  of VLA-4 and VLA-5 was nol 
affected by CC chemokines, indicating that altered avidity 
was independent  of surface expression  (data  not shown). 
Cytochalasin B abrogated chemokine-stimulated increases 
in adhesion to VCAM-1 and fibronectin (data not shown), 
implicating actin cytoskeleton-associated events in regula- 
tion  of avidity.  The results  show that  131  integrin  avidity 
can  be  sequentially  and  differentially  modulated  by  CC 
chemokines  in  monocytes.  Transient  activation  was  fob- 
lowed by rapid deactivation of VLA-4, while VLA-5 acti- 
vation occurred later and persisted. 
Kinetics of  Adhesive Strength of Chemokine-stimulated 
Monocytes to VCAM-I and Fibronectin Fragments 
To detect rapid changes in adhesive strength to VCAM-1, 
monocytes were prestimulated  with chemokines for vary- 
ing times in suspension, in contrast with static assays above 
where incubation with the chemokine and substrate  were 
coetaneous. Monocytes were allowed to attach to VCAM-1 
adsorbed at 10 txg/ml in a  parallel wall flow chamber at a 
low wall  shear stress  (0.5  dyn/cm  2) for 1 min,  and subse- 
quently subjected to detachment by incremental increases 
in  wall  shear  stress.  This  enabled  us  to  test  effects  of 
chemokines  on  adhesion  strengthening  at  early  time 
points. Attachment (~29 cells per field) was prevented by 
mAbs to VLA-4 but not altered by chemokines (data not 
shown), indicating that it was VLA-4 dependent  and that 
the  efficacy of initial  ligand  binding  by VLA-4 was  not 
modulated by chemokines. A  subset of unstimulated  cells 
bound  to VCAM-1  with  weak  adhesive  strength,  as evi- 
dent  by rapid  detachment  at low shear stresses  (~5  dyn/ 
cm2), whereas  another fraction remained  firmly attached 
at  high  shear  stresses  (,--~40 dyn/cm2),  indicative  of high 
avidity interactions  of VLA-4 with  VCAM-1  (Fig.  3 A). 
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Figure  2.  Sequential  regulation  of 
VLA-4 and VLA-5 by CC chemokines. 
(A-C).  Kinetics  of monocyte bmding 
to  fibronectin  without  (A)  or  after 
blocking with  mAb to VLA-5 (B)  or 
VLA-4 (C).  (D) Kinetics  of monocyte 
binding to fibronectin after stimulation 
wilh PMA and effect of Mn  =+ and acti- 
vating t51 mAb TS2/16 on regulation of 
monocyte binding by MIP-la.  (E and 
z)  Kinetics  of monocyte adhesion  to 
the  tibronectin  fragments  FN40  (El 
and FN120 (F).  Monocytes were sub- 
jected to adhesion assays on fibronec- 
tin  (adsorbed  at  2.5  ~gimt)  (A-D).  a 
~,0-kD (El or a  t20-kD fragment of fi- 
bronectin (F) (both adsorbed at 10 rig/ 
ml'l in  the presence of assay medium 
(control),  MIP-lcz (10 ng/mi), RANTES 
(100 ngiml}, MCP-t (I ngiml), or PMA 
(100 nM) at 37°C for indicated periods. 
Mn  2`  tl  raM) or [31 mAb TS2/16  (10 
~J,g/mi) was mi~ed with MIP-Ie~ (D). Some cells were preincubated with isotype control mAb 1X63 10 txg/ml) (All, mAb to VLA-5 (A5- 
FIIJI. t:100 ascites)  (B), or mAb to VLA-4 (HP2/t, 10 txg/ml) ((~  Data are mean -_~ SD of three independent experiments performed 
i.n Ouolicate. *. P < 0.0.5 vs the unstimulated control (B and Ei  ~, P < 001 vs the unstimuiated  control (B and El. 
Fewer  ceils  initially  attached  to VCAM-1  adsorbed  at  a 
~ower density of 5  txg/ml (~'-'  12 cells per  field), more cells 
readily detached at low shear, and few remained bound at 
nigh shear (Fig. 3 B). 
Examination of early time points with the shear flow as- 
say showed that MCP-1 (I ng/ml) induced a rapid increase 
in  adhesion  strengthening,  as  shown  by shear  resistance 
with a peak at  10 min, but subsequently reduced shear re- 
sistance  below the level of control cells (Fig. 3, i'1 and  C). 
This demonstrated  early activation of VLA-4 avidity and 
deactivation at time points of 12 min and later, consistent 
with deactivation  at  15 or 20 min in the static  assay. Re- 
suits  with MIP-loL in shear flow were also consistent with 
s.tatic assays.  MIP-lc~ (10 ng/ml) transiently  strengthened 
adhesion of monocytes with a peak :at [5 min and reduced 
it  below  control  levels  at  20-30 min  (Fig.  3  D).  Adding 
Mn: ~ or TS2/16 after stimulation  with chemokines for 20 
min  induced  shear  resistance  of :>85%  of cells,  showing 
that VCAM-t was functional when adhesive strength  was 
reduced by chemokines (Fig. 3, C and D; data not shown). 
The  chemokine-induced  increases  in  adhesion  strength 
(up to twofold at 8.5 dyn/cm  2) were most evident at low or 
medium  shear  forces (Fig. 3,  C  and  D; data  not shown), 
suggesting that intermediate  avidity states are most sensi- 
tive to regulation by chemokines.  By contrast, PMA elic- 
ited prolonged resistance  to detachment of >90%  of cells 
without deactivation at later time points (data not shown). 
The effect of CC chemokines on VLA-4-dependent adhe- 
sion  strengthening  to  VCAM-I  was  more  marked  on 
lower site density substrates than at 10 ixg/ml, since MCP-1 
enhanced  shear  resistance  threefold  at  8.5  dyn/cm-' and 
sevenfold at 36 dyn/cm  2 on VCAM-1 at 5 ixg/ml (Fig. 3 B). 
Cell attachment to VCAM-1 at higher shear (1 dyn/cm:) 
was twofold less efficient than at 0.5 dyn/cm  2. CC chemo- 
kines  failed  to  modulate  adhesion  strengthening  of this 
subset (data not shown), suggesting that a subset of mono- 
cytes  expressing  VLA-4 with  high  affinity  for  VCAM-1 
was selected, and that the adhesive strength of VLA-4 on 
this subset  of ceils could not be further regulated  by CC 
chemokines. 
Similarly, we studied  the kinetics  of adhesion strength- 
ening to the fibronectin fragments FN40 and FN120 both 
adsorbed  at 30 Ixg/ml.  Monocytes were allowed to attach 
in stasis  for 2 min and were subjected  to detachment  as- 
says. Attachment to FN40 (--,11  cells per field) and FN120 
(~-~!7 cells per field) was inhibited  by VLA-4 and VLA-5 
mAb, respectively (data not shown). The majority of on- 
stimulated cells attached to FN40 readily detached at low 
shear  stresses,  and  few  remained  bound  at  high  shear 
stresses  (Fig. 4  A). (?onsistent with  findings on VCAM-1, 
shear  resistance  was rapidly and  transiently  increased by 
MCP- l (1 ng/ml) at 5 and 10 rain (up to twofold at 8.5 dyn/ 
cm  2, P  <: 0.()1 vs  unstimuiated  control), subsequently  re- 
duced at 20 min (by up to 50%  at 36 dyn/cm  2, P  <0.05 vs 
unstimuiated  control),  and  was  not  significantly  further 
modulated at later time points (Fig. 4, A  and  B). Activa- 
tion and deactivation of adhesive strength by MIP-le~ oc- 
curred  slightly  later  than  with  MCP-1  (data  not  shown). 
On FNt20, a subset of unstimulated cells detached at low 
shear  stresses,  whereas  another  fraction  remained  firmly 
attached  at  high shear  stresses  (Fig. 4  C).  In accordance 
with the kinetics  of VLA-5 regulation  found in static  as- 
says, MCP-1 (1 ng/ml) or MIP-I~ (10 rig/rot) did not affect 
shear resistance after prestimulation  for up to 30 rain, but 
alarkedly increased adhesive strength at 40, 50, or 60 min 
(up to threefold at 8.5 dyn/cm  2, P  <  0.01 vs unstimutated 
control),  indicating  that  activation  of VLA-5  avidity oc- 
curred late  and was sustained  (Fig. 4. C  and  D; data not 
shown).  By contrast,  PMA  or Mn  2.  induced  immediate 
and prolonged resistance  to detachment of >90% of cells 
(data not shown). This confirmed sequential  regulation of 
VLA-4 and VLA-5 by CC chemokines. 
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Figure 3.  Rapid regulation by CC chemokines of monocyte adhe- 
sion strengthening on VCAM-1  under shear flow in controlled 
detachment assays. (A and B) Detachment profiles on VCAM-1 
adsorbed at 10 ~g/ml (A) and 5 ~g/ml (B) for monocytes prestim- 
ulated with MCP-1 (1 ng/ml). (C and D) Kinetics of regulation of ad- 
hesiveness on VCAM-1 (10 Ixg/ml) with MCP-1 (C) and MIP-la 
(D). Monocytes were prestimulated with MCP-1 (1 ng/ml, A-C) 
or MIP-la (10 ng/ml) (D) at 37°C for the indicated periods or 
held unstimulated (control) and perfused at 5 x  105 cells per ml 
for 1 rain through a flow chamber at 0.5 dyn/cm  2 to allow attach- 
ment.  Shear was then  increased every 10 s in increments, and 
numbers of cells per field remaining bound at the end of each 10-s 
interval were determined. In some experiments, Mn  2+  (1  mM) 
was added 20 min after stimulation with MCP-1  (C) or MIP-la 
(D), before shear resistance was determined (dashed lines). Data 
are mean _+ SD of three independent experiments performed in 
duplicate. 
Role of [31 Integrin Avidity in 
Transendothelial Chemotaxis 
MIP-lc~, RANTES, and, most effectively, MCP-1 induced 
chemotaxis of monocytes across resting HUVEC  via per- 
tussis toxin-sensitive G  protein-coupled receptors (Fig. 5 A; 
data not shown).  Treatment of HUVEC  with TNF-a for 
24  h  to upregulate expression of ICAM-1  and VCAM-1 
reduced chemotaxis to MCP-1 (Fig. 5 A). This reduction is 
specific for monocytes and MCP-1 and has been attributed 
to  an  impaired  chemotactic  gradient  and/or  desensitiza- 
tion  due  to  production  of MCP-1  by  cytokine-activated 
HUVEC  (12).  Inhibition with mAbs to the 132 subunit or 
ICAM-1 demonstrated a role of CDll/CD18 and ICAM-1 
in  transendothelial  migration  of  monocytes  to  MCP-1, 
MIP-lc~, or RANTES  (Fig. 5 A; data not shown).  Inhibi- 
tion was also achieved by mAbs to c~4 or [31, revealing the 
involvement  of  131  integrins  in  transendothelial  chemo- 
taxis (Fig. 5  A). Little inhibition was seen with a5 mAb. 
While  mAbs  to  132  or  ICAM-1  were  less  effective,  the 
mAb to a4 was more effective in inhibiting monocyte mi- 
gration to MCP-1  across TNF-e~-treated than resting HU- 
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Figure 4.  Regulation by MCP-I of monocyte adhesion strength- 
ening on a 40-kD (FN40) and a 120-kD (FNI20) fragment of fi- 
bronectin under shear flow in controlled detachment assays. (A 
and  C)  Detachment  profiles on FN40  (A) and FN120  (C)  ad- 
sorbed at 30 ~zg/ml for monocytes prestimulated with MCP-I (1 
ng/ml). (B and D) Kinetics of regulation of adhesiveness on FN40 
(B) and FN120 (D) adsorbed at 30 ~g/ml by MCP-1. Monocytes 
were prestimulated with MCP-1  (1 ng/ml) at 37°C for the indi- 
cated periods or held unstimulated (control), perfused at 5 ×  105 
cells per ml through a flow chamber, and allowed to attach for 2 
rain in stasis. Shear was then increased every 10 s in increments, 
and numbers of cells per field remaining bound at the end of each 
10-s interval were determined. Data are mean -+ SD of three in- 
dependent experiments performed in duplicate. *, P < 0.05 vs the 
unstimulated control (A and C) or time 0 (B and D); t, P  <  0.01 
vs the unstimulated control (A and C) or time 0 (B and D). 
VEC.  VCAM-1  mAb inhibited transmigration to MCP-1 
only across TNF-c~-treated HUVEC.  Inhibition by mAbs 
to VLA-4 was more marked than by the VCAM-1  mAb 
with stimulated HUVEC  (Fig. 5 A). These data suggest an 
involvement of VCAM-1  in chemotaxis across stimulated 
endothelium  and  interactions  of VLA-4 with  additional 
ligands, such as fibronectin. 
We studied the role of 131  integrin avidity in transendo- 
thelial monocyte chemotaxis. TS2/16 or Mn  2+ dose-depen- 
dently inhibited transendothelial chemotaxis of monocytes 
to CC chemokines both across resting and TNF-a-stimu- 
lated HUVEC  (Fig. 5 B; data not shown). Transmigration 
across  TNF-c~-stimulated  HUVEC  to  MCP-1  was  most 
sensitive to inhibition (Fig. 5 B; data not shown), consis- 
tent with the finding that MCP-1  most rapidly and effec- 
tively regulated  VLA-4  avidity for  VCAM-1  (Figs.  1,  C 
and D  and 3, C  and D). The dose-response for inhibition 
of chemotaxis  by  TS2/16  and  Mn  2+  correlated with  the 
dose-response for stimulation of [31 integrin affinity (data 
not shown). 
Jurkat T  ceils were used as a model for cells that consti- 
tutively express high avidity VLA-4. Binding to VCAM-1 
of IL-8  R2-transfected  Jurkat  T  cells (41)  was  constitu- 
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Figure 5.  Transendothelial chemotaxis of monocytes. (A) Inhibi- 
tion of chemotaxis to MCP-1 (100 ng/ml) with mAbs to adhesion 
molecules.  (B)  Inhibition of chemotaxis to  MCP-1  (100 ng/ml) 
with Mn  z+ or activating 131 mAb TS2/16. Monocytes were prein- 
cubated with or without (control) Mn  2+ or [31 mAb TS2/16 at in- 
dicated  concentrations for 20 min (B).  Endothelial monolayers 
on filters were untreated (open bars) or pretreated with TNF-c~ 
(100 U/ml) for 24 h (closed bars). Spontaneous migration in the 
absence of MCP-1  was 1.9  _+ 0.5%  and 2.7  _+ 0.3%  with resting 
and  activated  HUVEC,  respectively.  Data  are  mean  -+  SD  of 
three independent experiments performed in duplicate. 
tively high and increased only modestly by stimulation with 
IL-8, without deactivation at later time points (Fig. 6 A). 
IL-8  induced  transendothelial  migration  of  these  cells 
across resting HUVEC that was inhibited by mAbs to [32 
and ICAM-1 (Fig. 6 B). Treatment of HUVEC with TNF-a 
to induce expression of VCAM-1 reduced specific transen- 
dothelial  chemotaxis  of  Jurkat  transfectants  by  ~50%. 
This was reversed by mAbs to VLA-4 or VCAM-1 (Fig. 6 
B),  as mAb to VLA-4 and VCAM-1  had little effect on 
migration across unstimulated HUVEC, but significantly 
enhanced migration across TNF-c~-treated HUVEC (P < 
0.05 vs isotype control). These results suggest that an avid 
and irreversible VLA-4 interaction with VCAM-1 inhibits 
migration across stimulated HUVEC. 
Effect of fll Integrin Ligands on MCP-I Induced 
Monocyte Transmigration 
We  further  studied  the  role  of  VLA-4  and  VLA-5  in 
monocyte chemotaxis across Transwell-filters coated with 
their ligands. Interestingly, low site densities of the VLA-4 
ligands VCAM-I (2.5  ~g/ml) or FN40 (10 ~g/ml) allowed 
up to 60%  better monocyte transmigration to MCP-1  as 
compared to uncoated filters (Fig. 7 A). These effects were 
not seen at higher substrate densities (Fig. 7 A) and were 
most evident with MCP-1 at 1 ng/mt, a concentration opti- 
mally modulating VLA-4 avidity (data not shown). In con- 
trast, the VLA-5 ligand FN120 impaired transmigration to 
MCP-1 up to 70% at 30 txg/ml  (Fig. 7 A). The increase in 
transmigration with low density VCAM-1 or FN40 and the 
inhibition  with  FN120  was reversed by preincubation  of 
monocytes with [31 mAb (Fig. 7 B). An increase in trans- 
migration seen with fibronectin adsorbed at a tow density 
was inhibited to a much greater extent by mAb to a4 than 
to  a5  (data  not  shown).  Substrates  or  mAbs hardly  af- 
fected spontaneous transmigration (Fig. 7, A  and B). This 
provides  further  evidence  that  VLA-4  and  its  transient 
avidity regulation by CC chemokines is specialized in facil- 
itating monocyte chemotaxis to MCP-1. 
Discussion 
We have found that CC chemokines differentially regulate 
the avidity of the [31 integrins VLA-4 and VLA-5 in mono- 
cytes.  CC  chemokines  transiently  increased  and  subse- 
quently reduced  VLA-4-mediated binding of monocytes 
to VCAM-1, fibronectin, or FN40, a fibronectin fragment 
containing  the  CS-1  binding  site  for  VLA-4.  This  con- 
trasted with prolonged activation of VLA-4 by phorbol es- 
ter  and  reflected  rapid  activation  and  deactivation  of 
VLA-4,  resulting  in  attachment  and  subsequent  detach- 
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Figure 6.  Binding to VCAM-1  and transendothelial chemotaxis 
of Jurkat IL-8R2- transfectants. (A) Kinetics of IL-8R2-transfec- 
tant binding to VCAM-1. Jurkat lL-8R2-transfectants were sub- 
iected to adhesion assays on VCAM-1 (2.5 Ixg/ml) in the presence 
of assay medium (control) or IL-8 (100 ng/ml) at 37°C for indi- 
cated periods, after preincubation with mAbs to VLA-4 (HP2/1, 
10 Ixg/ml) or isotype control (X63, 20 Ixg/ml). (B) Chemotaxis of 
IL-SR2-transfectants  to  IL-8  (100  Ixg/ml).  Jurkat  IL-SR2-trans- 
fectants were preincubated with mAbs to 132, VLA-4a, or isotype 
control,  and  endothelial  monolayers  were  preincubated  with 
mAbs to ICAM-1 or VCAM-1. Endothelial monolayers were un- 
treated (open bars) or treated with TNF-c~  (100 U/ml) for 24 h 
(closed bars). Data are mean _+ SD of three independent experi- 
ments performed in duplicate. *, P  <0.05 vs the isotype control, 
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4. VLA-5 was confirmed to be the predominant receptor 
for fibronectin in monocytes. In contrast to deactivation of 
VLA-4, we found a persistent activation of VLA-5 avidity 
for fibronectin and the  RGD-containing fibronectin frag- 
ment FN 120. We have recently found that CC chemokines 
.rod other chemoattractants can also differentially regulate 
the avidity of 13l and [32 integrins (651. These .studies were 
on  eosinophils,  which  express  VLA-4 but  little  VLA-5, 
Chemoattractants stimulated transient activation of VI,A-4 
adhesiveness for VCAM-1 and fibronectin but prolonged 
activation of Mac- 1 (65). 
Fo our knowledge,  this  is  the  first  demonstration  that 
two integrins  sharing  the  same  [3  subunit  are  selectively 
and differentially regulated bv the same agonist. This sug- 
gests that the integrin ~x subunits confer differential activa- 
tion  of adhesiveness.  Studies  in  transfectants  have  pro- 
vided evidence that  the  cytoplasmic tail  of oz4 augments 
migration  but  reduces  localization  into  focal  adhesion 
complexes, whereas the ~x5  cytoplasmic tail  appears spe- 
cialized to promote spreading (10, 37). Since the cytoplas- 
mic domains of ex4 and a5  appear  to be crucial for their 
function in locomotion and are also required  for stimula- 
tion of adhesion by other cellular agonists, such as phorbol 
ester (36), the differential regulation of VLA-4 and VLA-5 
by CC chemokines may be due to differences  in  their ~ 
•  :ubunit cytopiasmic domains, eg., differential interaction 
with putative regulatory proteins (15). 
We  have  further shown that the  avidity of VLA-4 and 
VLA-5 can be regulated with sequential kinetics by cellu- 
lar agonists. Early and transient activation of VLA-4 pre- 
ceded the late and persistent activation of VLA-5 that oc- 
curred  concomitant  with  deactivation  of  VLA-4,  The 
regulation of VLA-4 avidity for VCAM-1, fibronectin, or 
FN40 by CC chemokines showed similar kinetics, indicat- 
ing that  it  was  ligand independent.  Adhesion  of formyl- 
methionyl-leucyl-phenylalanine receptor  transfectants  to 
VCAM-I  can  be  rapidly  and  transiently  upregulated  by 
formyl-methionyl-leucyl-phenylalanine (28).  In T lympho- 
cytes, CC. chemokines induce prolonged 131 integrin-medi- 
ated binding to secreted ECM (23)  and stinmlate  avidity 
of VLA4 and VLA-5 for fibronectin (9); however, differ- 
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Figure Z  Effect of 131 integrin ligands on monocyte chemotaxis 
to MCP-1 (A) and inhibition with 131 mAb (B). Transmigration of 
monocytes to assay medium (control) or MCP-1 (1 ng/ml) across 
Transwell-filters  coated  without  or  with VCAM-1,  FN40, fi- 
bronectin, or FN120 at indicated concentrations. Monocytes were 
preincubated  with isotype control mAb (X63, l0 ixg/ml) (A) or 
13l mAb (4B4, 1:100  ascites) (B) for 20 min. Data are mean ± SD 
of three independent experiments performed in duplicate. 
,'ntial contributions of these integrins at different time points 
were  not  investigated.  Hence,  sequential  activation  of 
VLA-4 and VLA-5 aviditv has not been previously noted, 
Overall,  the  effects  of  different  CC  chemokines  on 
VI,A-4 and  VLA-5 were  :similar.  Furthermore,  we have 
:ds,)  seen  transient  actwation  of  VLA-4  in  eosinophils 
(65). The mode (~f avidity regulation, early and transient or 
!ate and prolonged, therefore appears specific for the inte- 
grin  but  not  the  chemokine or cell  type; however,  there 
were  some  significant  differences  between  chentokines. 
Controlled detachment assays on VCAM-t or FN40 in shear 
flow  revealed  that  [VICP-I induced  early  modulation  of 
VLA-4 avidity, which was too rapid to be evident in static 
adhesion assays.  Of file chemokines. MCP-I most  rapidly 
increased adhesive strength of VLA-4 for VCAM-I. and 
deactivation also occurred most rapidly. Moreover, MCP-1 
was most active at low concentrations. This may be attrib- 
uted  to  differences  in  chemokine  receptor  density,  cou- 
pling  to  different  G-protein  heterotrimers  or  different 
kinetics of receptor occupancy (22). 
What are the mechanisms for the regulation of VLA-4 
and  VLA-5  avidity  by CC chemokines?  We  found  that 
monocyte attachment to VCAM-I  in  shear  flow was not 
altered  by chemokines, indicating that the  initial  binding 
of VLA-4 to VCAM-! was not changed. This implies that 
regulation of VI,A-4 avidity bv CC chemokines occurred 
after  ligand  binding.  Inhibition  of chemokine-stimulated 
monocyte adhesion  to  VCAM-I  and  fibronectin  by  cy- 
tochalasin B suggested that assembly or reorganization of 
fl~e actin cytoskeleton was involved in activation of both 
VLA-4 and  VL.A-5 avidity, Consistent with our findings, 
MIP-113 has been shown to induce lymphocyte adhesion to 
VCAM-I substrates without increasing affinity of VLA-4 
l\-)r soluble VCAM-I (35).  Postreceptor occupancy events 
have also been implicated in stimulation by phorbol ester 
of adhesion to fibronectin that is mediated by VLA-4 and 
VLA-5 but not accompanied by changes in ligand binding 
affinity (13,  i9). Recently, "EF-hand"-like divalent cation 
sites have been defined in the extracellular domain of oL4 that 
are essential for clustering and adhesive strength of VLA-4 
but not for monovalent |igand binding (Pujades,  C.,  S-K. 
Kraeff, R.  Alon, A. Masumoto, L. Burke, T,A. Springer, 
L.B. Chen, R.R Lobb, and M.E. Hernler, manuscript sub- 
mitted for publication), Hence, VLA-4 adhesiveness may 
be activated by juxtaposition or lateral multimerization in 
conjunction with changes in cytoskeletal associations (15). 
In monocytes stimulated  with  MIP-Ia on  VCAM-I, im- 
munofluorescence showed  uropod formation, actin  poly- 
merization, and asymmetrical distribution  of VLA-4 into 
uropod-like structures (Weber, C., and T.A. Springer. un- 
published  data).  Thus,  regulation of avidity may also  be 
associated with spatial redistribution of VLA-4. 
We assessed the contribution of integrins to transendo- 
theliat chemotaxis of monocytes. Our data show that mAb 
to t3 l, 132, et4, or c~5 independently inhibited transendothe- 
tial  chemotaxis.  The  relative  importance  of [32  integrins 
and ICAM-I was reduced,  that of VLA-4 was increased, 
and  that  of VCAM-1  was  only evident  across  activated 
HUVEC.  Activation  of  endothelium  has  recently  been 
shown to support VLA-4-mediated monocyte transmigra- 
tion (11). Inhibition was more marked with mAbs to VLA-4 
than to VCAM-1, suggesting that VLA-4 can interact with 
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transmigration of monocytes (46). Both VLA-4 and VLA-5 
may interact  with  fibronectin secreted by HUVEC  into 
the underlying ECM (33). Monocytes have been reported 
to use either 132 integrins or VLA-4 during spontaneous 
transendothelial migration or chemotaxis (11, 45).  How.- 
ever, our data suggest that these integrins may function in 
concert or at distinct steps to synergistically achieve opti- 
mal transendotheliai chemotaxis, particularly across acti- 
vated endothelium. This is consistent with an essential role 
of VLA-4 in emigration of monocytes to acute inflamma- 
tory sites in vivo (32, 66). 
We studied how the avidity state of 131 integrins affects 
the capacity for regulation by CC chemokines and trans- 
endothelial chemotaxis. Locking 131 integrins in a state of 
high affinity using activating 131 mAb TS2/16 or Mn 2~  (21, 
44) induced immediate and prolonged activation of VLA-4 
and VLA-5 in monocytes, which was dominant over the 
modulation  of avidity (e.g., VLA-4 deactivation) by CC 
chemokines. This was associated with strong inhibition of 
transendothelial  chemotaxis,  particularly  across  stimu- 
lated HUVEC and to MCP-1. Similarly, chemoattractants 
transiently activate VLA-4 in eosinophils (Weber, C., J. 
Kitayama,  and  T.A.  Springer, manuscript  submitted  for 
publication), and chemokine-induced migration of eosino- 
phils  across  HUVEC-  or  fibronectin-coated  filters  is 
blocked by the  stimulating  mAb  8A2,  which  appears  to 
freeze 131 integrins in a high avidity state (38). Therefore, 
the  modulation of VLA-4 avidity also appears to be re- 
quired  for  eosinophil  transendothelial  chemotaxis.  Ex- 
pression of VLA-4 in different cellular environments re- 
sults in multiple activation states that differ in constitutive 
avidity and capacity for stimulation of binding to different 
ligands  (9,  35,  36,  44).  As  a  model  for cells  expressing 
highly active VLA-4, we used Jurkat IL-8R2-transfectants 
(41). The CXC chemokine IL-8 only moderately increased 
the constitutively high adhesion of these cells to VCAM-I. 
without deactivation of VLA-4 at later time points. Migra- 
tion of Jurkat IL-8R2-transfectants to IL-8 across stimulated 
HUVEC was impeded by binding of the constitutively avid 
VLA-4 to VCAM-1, as shown by enhancement of migration 
by mAb to both VCAM-I  and VLA-4. Monocytes treated 
with TS2/16 and subjected to transendothelial chemotaxis 
were arrested on the apical surface of HUVEC monolay- 
ers without protruding into filter pores (Weber, C., and 
T.A. Springer, unpublished data).  Our data suggest  that 
high avidity states of VLA-4 interfere with migration, es- 
pecially across barriers expressing VCAM-I. 
Low or intermediate avidity of VLA-4 may be required 
to  allow  dynamic  regulation  by  CC  chemokines during 
transendothelial chemotaxis of leukocytes. In monocytes, 
the avidity of VLA-4 for fibronectin or FN40 appeared to 
be  more  substantially  activated  than  for VCAM-1.  This 
difference has been suggested to be characteristic of cells 
expressing VLA-4 with relatively low constitutive activity 
(44). Controlled detachment assays on VCAM-1  enabled 
us to differentiate between two major subsets  of mono- 
cytes, the first detaching readily at low or medium shear, 
the  other  remaining  bound  at  higher  shear.  Adhesion 
strengthening  was  optimally  upregulated  in  the  subset 
with  low or medium adhesive strength.  The shear resis- 
tance of cells selected by attachment at higher shear was 
not increased or decreased by CC chemokines. This con- 
firms that  high constitutive avidity impairs, whereas low 
constitutive avidity favors regulation of VLA-4. It has been 
predicted  that  intermediate  adhesion  strength  leads  to 
maximal motility (16). The properties of VLA-4 described 
herein are consistent with a  role in highly motile rather 
than stationary leukocyte phenotypes (40). 
The transient  nature  of VLA-4 avidity regulation and 
the  inhibitory  effects  of  high  avidity  VLA-4  states  on 
transendothelial migration suggested that VLA-4 is  spe- 
cialized in monocyte motility. Indeed, interaction of VLA-4 
with its ligands VCAM-I, FN40, or fibronectin allowed bet- 
ter monocyte chemotaxis to MCP-1  across filters coated 
with  these  substrates  at  low but  not  high  site  densities, 
without affecting spontaneous transmigration. As we have 
found that adhesion strengthening on VCAM-1 was more 
markedly regulated on lower site density substrates,  this 
infers that the regulation of VLA-4 avidity for its ligands 
by CC chemokines may serve to facilitate transendothelial 
chemotaxis. In contrast, interaction of VLA-5 with FN120 
impaired transmigration. However, reduction of monocyte 
chemotaxis  across  HUVEC  or  low  density  fibronectin- 
coated filters with or5 mAb suggested an involvement of 
VLA-5. Taken together, this may indicate that late activa- 
tion of VLA-5 may help complete transmigration if pre- 
ceded by or in concert with interactions of VLA-4 with its 
ligands. 
The regulation of 131 integrin avidity by CC chemokines 
may have important functional implications for leukocyte 
emigration and must be choreographed with regulation of 
132 integrin avidity in transendothelial chemotaxis. VLA-4 
and  132  integrins are  differentially used  during  adhesion 
and transendothelial migration of T lymphocytes (49), and 
distinct functions have been found for these integrins in 
the interaction of monocytes and T lymphocytes with en- 
dothelial monolayers in shear flow (42, 43). VLA-4 partic- 
ipates  in  adhesion  in  shear  flow to stimulated  endothe- 
lium,  whereas  132  integrins  mediate  firm  adhesion  and 
transmigration. A  recently proposed version of the multi- 
step model defined a role for c~4 integrins in bridging be- 
tween selectins and 132 integrin-mediated events (4). Both 
c~4137 and VLA-4 support rolling and attachment in flow on 
MAdCAM-1  and VCAM-1, respectively (1, 5). Transient 
activation and deactivation of VLA-4 avidity by chemo- 
kines may follow initial tethering and rolling of leukocytes 
through selectins and e~4 integrins, and may be important 
either in migration laterally along endothelium to an inter- 
endothelial cell junction where diapedesis can occur, or in 
diapedesis itself. Interaction of 132 integrins with ICAM-1 
and other ligands on endothelium may be most important 
in transendothelial migration. Late and prolonged activation 
of VLA-5 avidity for fibronectin may support interactions 
of leukocytes with  the  underlying  basement  membrane 
and with the ECM. This would comply with the sequential 
regulation of VLA-4 and VLA-5 avidity by chemokines. 
The specialization among 131 integrins in cellular modula- 
tion of their adhesive functions that we have demonstrated 
may be important for accomplishing the complex process 
of leukocyte extravasation. 
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